Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018) CANCER MED-US
Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma Front Immunol
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials Haematologica
G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy Front Immunol
MYC activation impairs cell-intrinsic IFNy signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer Cell Rep Med
Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation J EXP MED
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis J Immunother Cancer
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders CRIT REV CL LAB SCI
